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Abstract
Background: Sensory deprivation induces dramatic morphological and neurochemical changes in the olfactory bulb (OB)
that are largely restricted to glomerular and granule layer interneurons. Mitral cells, pyramidal-like neurons, are resistant to
sensory-deprivation-induced changes and are associated with the precursor to brain-derived neurotrophic factor (proBDNF);
here, we investigate its unknown function in the adult mouse OB.
Principal Findings: As determined using brain-slice electrophysiology in a whole-cell configuration, brain-derived
neurotrophic factor (BDNF), but not proBDNF, increased mitral cell excitability. BDNF increased mitral cell action potential
firing frequency and decreased interspike interval in response to current injection. In a separate set of experiments,
intranasal delivery of neurotrophic factors to awake, adult mice was performed to induce sustained interneuron
neurochemical changes. ProBDNF, but not BDNF, increased activated-caspase 3 and reduced tyrosine hydroxylase
immunoreactivity in OB glomerular interneurons. In a parallel set of experiments, short-term sensory deprivation produced
by unilateral naris occlusion generated an identical phenotype.
Conclusions: Our results indicate that only mature BDNF increases mitral cell excitability whereas proBDNF remains
ineffective. Our demonstration that proBDNF activates an apoptotic marker in vivo is the first for any proneurotrophin and
establishes a role for proBDNF in a model of neuronal plasticity.
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Introduction
The loss of sensory afferents (i.e. inputs) induces cell death in
target brain regions or nuclei [1–5]. The neurons that die
following sensory deprivation differ across modalities and are
tissue-specific. Visual [2] and auditory [3] nuclei respond to
sensory loss by losing relay or projection neurons. Interneurons die
following loss of sensory input to the spinal cord dorsal horn [4]
and to the olfactory bulb (OB) [1,5–7]. OB interneuron
morphologic degeneration can be induced by both deafferentation
(direct insult to the peripheral neuron) [6,8] and by sensory
deprivation (indirect insult by loss of odorant stimulation)
[5,7,9,10]. Olfactory sensory deprivation via unilateral naris
occlusion was developed to better elucidate the regulation of
neonatal OB development [9,11], and has also been a useful
model of neuronal insult in the adult mouse [6,7,10,12,13].
Mouse OB interneurons are differentially sensitive to sensory
deprivation induced by unilateral naris occlusion. Catecholamine
interneurons, in the glomerular layer, have been shown to be
particularly sensitive to naris occlusion. In the odor-deprived bulb,
relative to the contralateral control OB, catecholamine loss has
been measured by lower dopamine concentration [9,12,14], lower
TH expression and activity [12], loss of tyrosine hydroxylase (TH)
immunoreactivity [6,10], and also by increased DNA fragmenta-
tion in the glomerular layer [5]. Thus there is evidence for a loss of
cellular phenotype and for total cell death. The mechanism
underlying this interneuron loss in the mouse OB is still unknown.
Following sensory deprivation granule cells, the other major class
of OB interneurons, express activated-caspase 3 [7], an enzyme
involved in neural plasticity and apoptosis. OB catecholamine
neurons have not been shown to express activated-caspase 3
following loss of sensory input, however, these neurons are
immunoreactive for activated-caspase 3 prior to methamphet-
amine-induced apoptosis [15].
Previously we investigated the role of brain-derived neuro-
trophic factor (BDNF) following OB sensory deprivation. BDNF
immunohistochemistry revealed a selective loss of BDNF-immu-
noreactive fibers from the most superficial extent of the external
plexiform layer [13]. This layer is known to shrink in size following
naris occlusion [11,16] and contains processes of glomerular
interneurons [17]. At the same time, mitral cells appeared to gain
BDNF immunoreactivity. We also found that the major BDNF
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proBDNF [13]. Neurotrophins are secreted as ‘pro’ isoforms (i.e.
proBDNF, proNGF) [18] and require processing by an extracel-
lular protease that will cleave the pro domain from the mature
neurotrophin. ProBDNF has been considered an inactive
precursor prior to cleavage by the serine protease plasmin and
other selective matrix metalloproteinases [18–21]. The activated
or mature BDNF can then serve as a ligand for the tropo-
myosin-related kinase B (TrkB) receptor and promote cell
survival and synaptic plasticity [19]. However, proBDNF can also
directly bind to and activate TrkB [22]. All proneurotrophins have
higher affinities for the p75 neurotrophin receptor (p75NTR),
which lacks a kinase domain, than for their respective Trk
receptors [18,23,24]. Proneurotrophin activation of p75NTR
can induce cell death [18,23–26]. It is unknown if proneuro-
trophins can induce cell death in vivo. Interestingly, mouse mitral
cells express TrkB [27,28], but do not express p75NTR [16,27]
and respond to BDNF stimulation with a reduction in voltage-
gated potassium current in vitro [29,30]. The molecular targets
for BDNF-induced current suppression are three tyrosine residues
on the N- and C- terminal aspects of the Kv1.3 channel that
become phosphorylated [29]. OB glomerular layer interneurons
express p75NTR [16,27] but not TrkB [27]. While suppression of
Kv1.3 would be predicted to increase mitral cell excitability,
current-clamp studies have never been performed. Our goal,
therefore, was to investigate a direct action of mature versus
proBDNF on mitral cells via activation of the TrkB receptor
kinase.
In the present study we hypothesized that proBDNF alters adult
mouse OB function both acutely and chronically by action on two
different neurotrophin receptors expressed in different neuronal
types. Acute effects by proBDNF were predicted to be mediated by
the mitral cell TrkB receptor and could be measured by changes in
electrical excitability. Conversely, proBDNF chronic effects were
predicted to be mediated by p75NTR as expressed in the
glomerular interneuron and could be measured by an increase
in activated-caspase 3 immunoreactivity and a loss of TH
expression.
Results
BDNF, but not proBDNF, increases mitral cell excitability
Voltage-clamp studies have established that BDNF-evoked
activation of TrkB causes current suppression of mitral cell
outward current attributed to multiple phosphorylation of the
predominant voltage-gated potassium channel, Kv1.3 [28–32].
Since the mouse OB expresses more proBDNF than it does
mature BDNF [13], we sought to determine if both proBDNF and
BDNF were active ligands in the mouse OB. Mitral cells were
identified in OB slices as large, pyramidal cells in a discreet layer
when viewed with infrared optics [33]. BDNF bath application
modulated the threshold to the first action potential so that 4 out
of 4 mitral cells fired at a lower intensity of current injection;
measured as an average of 100 pA before versus that of 69 pA
following BDNF addition (Figure 1A). Overall, mitral cells
significantly increased spike firing frequency (the total number of
spikes per 1s sweep or Hz) after BDNF bath application (N=4,
BDNF treatment effect, two-way ANOVA, a#0.05) (Figure 1B).
Mitral cells undergo the firing of intermittent clusters of action
potentials (APs), defined as a spike cluster of three or more APs
separated by pauses of less than 100 ms [33,34], which were
observed despite the short current injections of our experimental
design (Figure 1A). Due to the intrinsic membrane properties of
these neurons and our shorter current injection paradigm, we
elected to also measure the time between spikes (interspike
interval, ISI) as calculated across the duration of the current
injection. The duration of the ISI was significantly shorter after
BDNF stimulation (N=4, BDNF treatment effect, two-way
ANOVA, a#0.05) (Figure 1C).
Since proBDNF has been reported to bind to and activate TrkB
[22], we thereby tested the precursor for similar modulation as
observed for the mature neurotrophin. Unlike BDNF, however,
bath application of cleavage-resistant proBDNF did not induce
mitral cells to fire an action potential at lower current intensity (1
out of 5; 75 vs 85 pA) nor did proBDNF modulate frequency
(Figure 2A, C) or ISI (Figure 2C) (N=4, proBDNF treatment
effect, two-way ANOVA, a$0.05). Denatured BDNF (BDNF
heated to 95uC for 10 minutes) served as a protein control.
Application of denatured BDNF failed to increase mitral cell
excitability as measured by frequency and ISI (N=4, denatured
BDNF treatment effect, two-way ANOVA, a$0.05) (Figures 2B
and D). None of the treatments (BDNF, proBDNF, and denatured
BDNF) significantly altered the latency to first spike (data not
shown) nor were any significant at a given current step (Bonferroni
a$0.0083).
BDNF-evoked increase in mitral cell firing is dependent
upon Kv1.3 ion channel
The Kv1.3 channel carries approximately 40–60% of the
outward current in mitral cells, as demonstrated by gene-targeted
deletion or pharmacological block [29,32,35]. BDNF modulation
of Kv1.3 current is prevented by pre-treatment with the selective
channel pore-blocking peptide, margatoxin (MgTX), using a
primary cell culture preparation in conjunction with voltage-clamp
experiments [29]. In order to determine that BDNF-evoked
increase in AP firing frequency was attributed to Kv1.3 current
suppression, we first characterized MgTX stimulation of the mitral
cell using the current-clamp configuration of the OB slice. First,
mitral cells were stimulated with the same series of current
injections before and after bath application of 1 nM MgTX.
Similar to the effect of BDNF, 3 out of 4 mitral cells treated with
MgTX bath application fired action potentials at a lower intensity
of current injection; measured as an average of 131 pA before
versus that of 81 pA following MgTX addition. MgTX bath
application significantly modulated mitral cell excitability as
measured by frequency (N=5, MgTX treatment effect, two-way
ANOVA, a#0.05) (Figure 3C) and by ISI (N=5, MgTX
treatment effect, two-way ANOVA, a#0.05) (Figure 3D). MgTX
at this concentration partially blocks homomeric Kv1.3 channels,
but not heteromeric Kv1.3 channels in non-neuronal cell types
[36,37]. Importantly, MgTX pre-treatment completely blocked
BDNF modulation of spike frequency and ISI (N=3, BDNF
treatment effect, two-way ANOVA, a$0.05) (Figure 3B–D). This
demonstrated that BDNF modulation of spike frequency and ISI is
dependent upon Kv1.3 channel conductance. Like the neurotro-
phin treatments, MgTX did not significantly alter the latency to
first spike (data not shown) nor was it significant at a given current
step (Bonferroni a$0.0083).
Intranasal delivery of proBDNF mimics sensory
deprivation evoked by naris occlusion
Since proBDNF failed to alter mitral cell excitability in the
acute slice preparation, we surmised that it may act through
another neurotrophin receptor. Adult mouse OB glomerular layer
interneurons, but not mitral cells, express p75NTR [16,27] and
are prone to sensory deprivation-induced cell death [5].
Furthermore, proBDNF can induce apoptosis in p75NTR-
Olfactory Bulb Precursor Neurotrophin Function
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e31978dependent manner in vitro [26,38]. The p75NTR lacks a kinase
domain but is associated with apoptosis and cellular pruning [23].
Thus, we tested whether chronic application of proBDNF by
intranasal delivery (IND) could induce a phenotype reminiscent of
cell loss and plasticity in the mouse OB glomerular layer in vivo.
Adult mice were given PBS, BDNF, or proBDNF IND once a day
for five days and then were sacrificed 24 hours after the last
treatment [39]. The mice were then fix perfused and the OBs were
processed for immunofluorescence with antiserum against the
apoptotic and plasticity marker activated-caspase 3 (see Methods).
Few activated-caspase 3 immunoreactive glomerular layer inter-
neurons were present following either PBS or mature BDNF
treatment (Figure 4A). In contrast, activated-caspase 3 immuno-
reactive neurons were approximately 3-fold more abundant in the
proBDNF treatment group (Figure 4A). The effect of proBDNF
treatment was significant as compared to either PBS or mature
BDNF treatment (N=3, one-way ANOVA, snk, a#0.05). The
number of activated-caspase 3 positive neurons is not different
between the PBS and mature BDNF treatment groups (Figure 4A)
(N=3, one-way ANOVA, snk, a$0.05). Next, we immunolabeled
adjacent sections with an antiserum directed against TH in order
to identify glomerular catecholamine interneurons (see Methods).
TH immunolabeling could be seen throughout the glomerular
layer following treatment with PBS, BDNF, or proBDNF
(Figure 4B). However, compared to both PBS and mature BDNF,
proBDNF significantly reduced the number of TH immunoreac-
tive glomerular layer interneurons soma (N=3, one-way AN-
OVA, snk, a#0.05) (Figure 4B). Thus, proBDNF simultaneously
reduces TH immunoreactivity and enhances activated-caspase 3
immunoreactivity.
Next we sought to compare the activated-caspase 3 and TH
immunoreactivity seen following IND to a model of neuronal loss
and plasticity, olfactory sensory deprivation (Figure 5). Similar to
the IND treatment groups, adult mice underwent 5 days of naris
occlusion. Prior to sacrifice, animals were visually confirmed to
have complete naris closure [11,13]. As before, we first
investigated activated-caspase 3 immunoreactivity. Here the
treatment groups consisted of sham (control), contralateral to the
nariso cclusion (open), and ipsilateral to the naris occlusion
(occluded). Activated-caspase 3 immunoreactive neurons were
Figure 1. BDNF increases mitral cell excitability. (A) Representative action potential trains in a mitral cell in response to various current
injections of 1000 ms duration before (left) and approximately 10 min after 10 ng/ml BDNF bath application (right). The resting membrane potential
was held near 265 mV. (B) Line graph of the mean (6 s.e.m.) spike frequency (Hz) evoked at each current injection as recorded in A. Closed circles
(black) represent data before BDNF stimulation and open circles (red) represent the same neurons after BDNF stimulation. (C) Line graph of the mean
(6 s.e.m.) interspike interval (ISI) at each current injection. Data were fit with linear regressions to facilitate visualization. BDNF had a significant
treatment effect for both rate and ISI; two-way ANOVA (N=4; p,0.05).
doi:10.1371/journal.pone.0031978.g001
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occlusion as compared to either the control or the open treatment
groups (one-way ANOVA, snk,N = 3 ,a#0.05). TH immunore-
activity was robust following control and open treatments, but
weak following naris occlusion (Figure 5B). Naris occlusion
significantly reduced TH immunoreactivity in the OB glomerular
interneuron soma (N=3, one-way ANOVA, snk, a#0.05)
(Figure 5B). To control for any possible OB shrinkage following
either naris occlusion [11] or IND, the perimeters of three OB
sections, from which the 12 fields of view were taken, were traced
and the total area (mean 6 s.e.m.) was calculated as the sum of
these sections (see Methods). Naris-occlusion treatment—control
(102.865.4 mm
2), open (110.367.3) and occluded (101.968.6)—
had no significant effect on OB area (N=3, one-way ANOVA,
snk, a$0.05). Similarly, none of the IND treatments—PBS
(107.168.0 mm
2), mature BDNF (102.361.1), and proBDNF
(97.467.7)—significantly altered OB area (N=3, one-way AN-
OVA, snk, a$0.05).
Discussion
ProBDNF is an active ligand in the mouse olfactory bulb in vivo.
This novel finding was demonstrated when proBDNF IND
produced a phenotype similar to that seen following short-term
adult naris-occlusion. Both treatments decreased TH and
increased activated-caspase 3 immunolabeling in glomerular layer
interneurons. This is the first demonstration of a proneurotrophin
inducing a marker of apoptosis in vivo. In the OB slice preparation,
mitral cells were electrically stimulated via a whole-cell patch-
clamp electrode. Bath application of BDNF, but not proBDNF,
increased mitral cell spike frequency and initiated spike firing at
lower amplitude current injections. Similarly, MgTX mimicked
the effect of BDNF on mitral cell spike frequency and initiated
spike firing at lower amplitude current injections. Given that
MgTX selectively blocks Kv1.3 channels, the mechanism of
BDNF modulation of mitral cell excitability is likely via Kv1.3
current suppression that has been shown to be mediated by TrkB-
Figure 2. Neither proBDNF nor denatured BDNF increase mitral cell excitability. (A–B) Representative action potential trains in mitral cells
in response to 75 pA current injections of 1000 ms duration before (left) and approximately 10 min after (right) bath application of either 10 ng/ml
proBDNF (A) or 10 ng/ml denatured BDNF (B, denBDNF). The resting membrane potential was held near 265 mV. (C–D) Line graphs of the mean (6
s.e.m.) spike frequency (Hz) and of the mean (6 s.e.m.) ISI at each current injection as recorded in A and B before (closed circles; black) and after
(open circles; red) proBDNF (C) or denatured BDNF (D). Data were fit with linear regressions to facilitate visualization. Neither treatment had a
significant effect upon either rate or ISI; two-way ANOVA (N=4; p$0.05).
doi:10.1371/journal.pone.0031978.g002
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C- terminal aspects of the Kv1.3 channel [29]. Evoked potassium
currents in cultured mouse and rat mitral cells are reduced by
,35% after BDNF application [29,30]. Moreover, cultured mitral
cells pre-treated with MgTX do not respond to subsequent BDNF
stimulation [29,30], an effect reproduced here in the brain slice
preparation. In fact, even though Kv1.3 2/2 mice exhibit a 7
fold increase in TrkB expression, application of BDNF to cultured
mitral cells remains ineffective to suppress outward current due to
lack of the channel target [32].
Here we measured the effect of BDNF isoforms on mitral cells
in a slice preparation. It was interesting that a physiological
concentration of BDNF (10 ng/ml) [40,41] increased mitral cell
responses to low amplitude current injections but not to larger
amplitude current injections. The fact that BDNF had a stronger
effect at lower amplitude current injections may be a dose-
dependent property in common with other receptor tyrosine
kinases. Activation of the insulin receptor kinase allows mitral cells
to increase spike frequency and spike adaptation at higher
amplitude current injections [33]. The fact that the unprocessed
BDNF isoform, proBDNF [18], is more abundant in the mouse
OB [13,16], yet did not alter mitral excitability at any amplitude
current injection indicates that mitral cells in vivo are likely to be
surrounded by suitable concentrations of mature BDNF. The total
amount of OB BDNF is still low in comparison to that measured
in other brain regions [16,40,42]. We conjecture that plasminogen
and tissue plasminogen activator—the enzymatic system that
cleaves proBDNF in the hippocampus [21]—are expressed in the
extracellular space around mitral cells creating local gradients for
both proBDNF and mature BDNF.
Our pharmacological results corroborate data from the Strow-
bridge Laboratory, that demonstrate that low concentrations of 4-
aminopyridine (4-AP), a broad potassium channel blocker [43,44],
increases mitral cell firing frequency and burst length [34].
Electrically-stimulated mitral cells generate sub-threshold oscilla-
tions that involve the slow-inactivating potassium current [34,45].
The slow-inactivating potassium current ID is associated with
Kv1.3 [34,35,46]. 4-AP is thought to increase mitral cell evoked
activity and burst length through channels containing Kv1.3 and
other Shaker subunits [34]. MgTX was cloned from scorpion
venom and was found to maximally inhibit Kv1.3 currents at
110 pM [47]. One nM MgTX has been reported in non-neuronal
cells to partially block Kv1.3 homomeric channels and not
heteromeric Kv1.3 channels [36,37] and has been used to block
homomeric Kv1.3 currents in cultured neurons [48,49]. The
combinations of Shaker alpha subunits expressed by mitral cells,
however, are currently unknown. Pharmacological studies have
demonstrated that 1.0 nM MgTX can also inhibit Kv1.1 currents
[50], but has no effect on Kv1.2 [51], Kv1.4 [51], Kv1.5 [37,51],
Kv1.6 [47,51], and Kv1.7 and Kv1.8 [51] currents. Furthermore,
in tissue preparations, 1.0 nM MgTX has been used to selectively
separate Kv1.3 currents in choroid plexus [52], 5 nM MgTX has
been used on aspiny forebrain neurons [53], and 10 nM MgTX
has used to increase presynaptic excitability in the calyx of Held
[54]. It is interesting to speculate that cells with a modest response
to 1.0 nM MgTX (i.e. Figure 3B) would be strongly inhibited by a
Figure 3. Margatoxin increases mitral cell excitability. (A) Representative action potential trains in a mitral cell in response to a 75 pA current
injection of 1000 ms duration before (left) and approximately 10 min after 1 nM Margatoxin (MgTX) bath application (right). (B) Representative action
potential train in a mitral cell in response to a 100 pA current injection of 1000 ms duration before (left) and after after MgTX (center) and then after
subsequent 10 ng/ml BDNF bath addition (right). The resting membrane potential was held near 265 mV. (C) Line graph of the mean (6 s.e.m.) spike
frequency evoked at each current injection as recorded in A and B. Closed black circles represent data before BDNF stimulation (Before) and open red
circles represent the same neurons after MgTX stimulation (MgTX). Open red squares represent the subsequent application of BDNF while
maintaining MgTX block (MgTX+BDNF) as in B. (D) Line graph of the mean (6 s.e.m.) ISI at each current injection. Data were fit with linear regressions
to facilitate visualization. MgTX has a significant treatment effect for both parameters; two-way ANOVA (N=5; p#0.05). BDNF application following
MgTX did not significantly alter either rate or ISI; two-way ANOVA (N=3; p$0.05).
doi:10.1371/journal.pone.0031978.g003
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providing evidence for multiple Shaker currents. Other work in our
laboratory suggests that Kv1.3 forms heteromers with other Shaker
subunits in the OB, which are potentially modulated by adaptor
proteins and phosphorylation [55]. Therefore, heterogeneity in
mitral cells might exist based either upon Kv subunit stoichiometry
or channel interactions with adaptor proteins, or a combination of
both. It has been recently proposed the heterogeneous responses of
mitral cells to current injections may add to neural coding of odors
[56]. Varying the composition of Shaker channels is a potential
mechanism used by mitral cells to achieve heterogeneity.
Unlike potassium channel pharmacological data previously
reported in mitral cell slices, we did not see any changes in the
latency to first evoked action potential [34]. This is likely due to
differences in experimental design. In the previous study, mitral
cells were stimulated with longer current injections (5s) and
thereby the resulting latencies (800 to 1200 ms) were nearly as
long, or longer than, our total pulse duration (1s) and were also
Figure 4. ProBDNF intranasal delivery (IND) increases activated-caspase 3 immunoreactivity and reduces tyrosine hydroxylase
immunoreactivity. (A) Representative photomicrographs taken of the mouse glomerular layer following a five day treatment of: PBS, mature BDNF,
or proBDNF as administered by IND. Cryosections were incubated with activated-caspase 3 antiserum (1:100) (red) and with DAPI nuclear stain (blue)
to visualize immunoreactive glomerular cells. Bar plot of the mean (6 s.e.m.) number of activated-caspase 3 immunoreactive glomerular cells per
treatment condition per 93,500 mm
2 field of view. (B) Same as in A but cryosections were incubated with tyrosine hydroxylase (TH) antiserum
(1:4,000) (red). *=Significantly-different by a one-way ANOVA with a Student-Newman-Keuls post-hoc test (snk)( N=3 ,a#0.05).
doi:10.1371/journal.pone.0031978.g004
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no effect on the latency to first evoked action potential was
observed for our study in which the pulse duration was likely too
short to accurately access this variable.
When proBDNF failed to increase mitral cell excitability we
explored an alternative function in the glomerular layer. Sensory
deprivation via naris occlusion reduces the number of proBDNF
immunoreactive glomerular cells [13] and can induce cell death in
the OB glomerular layer [5]. Glomerular interneurons express the
p75NTR [16,27] that can induce apoptosis [23]. Both proBDNF
and pro-nerve growth factor (proNGF) have a higher affinity for
the p75NTR than for their respective Trk receptors [18,23,24].
The increased affinity for p75NTR by proneurotrophins is likely
due to binding to the p75NTR co-receptor sortilin [23–26].
Regardless of the ligand-receptor interaction, both proBDNF and
proNGF have been shown to induce p75NTR dependent cell-
Figure 5. Five days of naris occlusion increases activated-caspase 3 immunoreactivity and reduces tyrosine hydroxylase
immunoreactivity. (A) Representative photomicrographs taken of the mouse glomerular layer following five days of sham (control), contralateral to
the naris occlusion (open), and ipsilateral to the naris occlusion (occluded) treatment. Cryosections were incubated with activated-caspase 3
antiserum (1:100) (red) and DAPI nuclear stain to visualize immunoreactive glomerular cells. Bar plot of the mean (6 s.e.m.) number of activated-
caspase 3 immunoreactive glomerular cells per treatment condition per 93,500 mm
2 field of view. (B) Same as in A but cryosections were incubated
with tyrosine hydroxylase (TH) antiserum (1:4,000) (red). *=Significantly-different by a one-way ANOVA with a Student-Newman-Keuls post-hoc test
(snk)( N=3 ,a#0.05).
doi:10.1371/journal.pone.0031978.g005
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apoptosis in smooth muscle cells, sympathetic neurons, and in a
pheochromocytoma cell line [18] in vitro. ProNGF immunoreac-
tivity precedes cell death in oligodendrocytes in an in vivo model of
nerve damage [25]. Examining the glia in the dying nerve at
multiple time points reveals that the oligodendrocytes first
upregulate p75NTR and caspase 3 before succumbing to
apoptosis [25], indicating a causal relationship. Our data show
that application of proBDNF, but not BDNF, induces a proteolytic
enzyme involved in apoptosis and plasticity (activated-caspase 3)
[7,15,23,25,39,57,58] in the glomerular layer and represents the
first demonstration that application of a proneurotrophin activates
an apoptotic marker in vivo. Interestingly, proBDNF reduced the
number of TH immunoreactive cells in the glomerular layer in a
manner that mimicked the phenotype of adult naris-occlusion
[6,12,59]. The same effective proBDNF dose used in our studies
(10 ng/ml; 0.2 nM), also induced apoptosis in sympathetic
ganglion neurons [26] and cerebellar granule neurons [38] in vitro.
Previous studies have also demonstrated a reduction in the
number of TH immunoreactive glomerular interneurons in
response to adult naris-occlusion [6,12,59]; additionally, we report
that short-term naris-occlusion enhanced activated-caspase 3
immunoreactivity. Thus, both short-term naris-occlusion and
proBDNF administration reduces TH and enhances activated-
caspase 3 immunoreactivity. Activated-caspase 3 immunoreactiv-
ity following naris occlusion supports previous studies demonstrat-
ing neuronal degeneration in the mouse [6] and DNA fragmen-
tation in the rat [5] in the glomerular layer following
deafferentation and sensory deprivation, respectively. In contrast,
mouse naris-occlusion has been reported to only reduce TH
expression and not to induce cell loss [12]. Anecdotally, mouse
olfactory nerve axotomy does not induce DNA fragmentation in
mouse glomerular layer interneurons [60]. Recently, deafferenta-
tion was reported to reduce the number of TH immunoreactive
neurons, but not the total number of glomerular interneurons [59].
This conflict may be due to differences in the age of mice. We used
young adult mice in the IND experiments in order to keep the age
difference between the animals used in the physiology and
histology experiments at a minimum. The result was that our
animals were about 3 weeks younger than those used by the other
groups [12,59]. Alternatively, activated-caspase 3 may be a
mechanism by which sensory input, or lack thereof, regulates
synapse and dendrite plasticity [58]. Indeed, after sensory input
loss the OB undergoes extensive synaptic remodeling and neurite
pruning as measured at the histological, receptor and physiological
level [6,13,30,61–63]. Furthermore, proliferating neurons of the
olfactory bulb, including those in the glomerular layer, briefly
express activated-caspase 3 [64]. Therefore, activated-caspase 3
may not be functioning as an apoptotic marker, but instead as a
plasticity marker in the mouse glomerular layer.
Our data provide a role for proBDNF in the mouse olfactory
bulb and have potentially important implications for therapies that
target diseases of neuronal death. Multiple studies have shown that
BDNF improves locomotor ability in rodents following experi-
mental ischemia-induced neuronal loss [65–67]. ProBDNF levels
are reduced in the cortices of human patients that are developing
and living with Alzheimer’s disease, a condition of massive
neuronal loss [68–70]. Strikingly, in another human disease of
progressive neuronal death, amyotrophic lateral sclerosis (ALS or
Lou Gehrig’s Disease), intravenous infusions of BDNF were shown
to improve the respiratory capabilities of late-stage patients [71].
Intravenous application of BDNF, nonetheless, is inefficient due to
the poor blood brain barrier permeability of BDNF and to
deleterious side effects [71]. As a result, small molecule ligands for
p75NTR and TrkB are being developed as therapeutic agents for
diseases of neuronal death [70,72]. The mouse OB is an exciting
model to investigate BDNF and proBDNF actions in vivo on easily
identifiable, central nervous system neurons that express either
p75NTR or TrkB, but not both.
Materials and Methods
Ethics statement
All experiments described in this report were approved by the
Florida State University Institutional Animal Care and Use
Committee (IACUC) under protocol #9912 and were conducted
in accordance with the American Veterinary Medicine Association
(AVMA) and the National Institutes of Health (NIH).
Animal Care
All mice (strain C57BL6/J) were housed at the Florida State
University vivarium in accordance with institutional requirements
for animal care and were maintained on a standard 12/12 hour
light/dark cycle. Both male and female mice were incorporated
into our experiments and were allowed access to food and water ad
libitum.
Antisera and neurotrophins
The rabbit-activated caspase-3 antiserum was used at a final
dilution of 1:100 (Promega, Madison, WI, USA) and the mouse
tyrosine hydroxylase antiserum was used at 1:4,000 (ImmunoStar,
Hudson, WI, USA). Neurotrophins were made as a 1 mM stock
solution in 0.1% bovine serum albumin (BSA) in phosphate-
buffered saline (PBS) and frozen as individual aliquots at 280uC
until use. Recombinant cleavage-resistant, mouse probrain-derived
neurotrophic factor (proBDNF, B-243) and recombinant human
BDNF (B-250) were from Alomone (Alomone, Jerusalem, IL). PBS
was made as previously [30]. All other reagents were acquired from
Sigma-Aldrich or Fisher Scientific (Suwannee, GA, USA).
Slice preparation
Postnatal day 15–35 (P15–35) mice were anesthetized to a
surgical plane using gaseous isoflurane in a bell jar (Aerrane;
Baxter, Deerfield, IL). The animals were rapidly decapitated and
the OBs exposed by removing the dorsal and lateral portions of the
cranium between the cribriform plate and the lambda suture [73].
After removing the dura, the OBs were quickly removed, glued
down to a sectioning block with a cyanoacrylate adhesive (i.e.
Super Glue) and submerged in oxygenated, ice-cold, sucrose-
modified artificial cerebrospinal fluid (ACSF). Sucrose-modified
ACSF contained (in mM): 83 NaCl, 26.2 NaHCO3, 1 NaH2PO4,
3.3 MgCl2, 0.5 CaCl2, 72 sucrose, and 22 D-glucose; 310–320
mOsm, pH 7.3. Horizontal sections (275–350 mm) were cut in
oxygenated, ice-cold, sucrose-modified ACSF using a Series 1000
Vibratome. Sections were then incubated in oxygenated, sucrose-
modified ACSF at 33uC for 30 minutes and then maintained at
room temperature in normal ACSF until needed [74]. ACSF
contained (in mM): 119 NaCl, 26.2 NaHCO3, 1 NaH2PO4, 2.5
KCl, 1.3 MgCl2, 2.5 CaCl2 and 22 D-glucose; 300–310 mOsm,
pH 7.3. Prepared slices were maintained in an interface chamber
containing oxygenated ACSF for up to 8 hours to retain health of
tissue prior to recording.
Electrophysiology
Membrane voltage was measured in the whole-cell configura-
tion and controlled by pClamp 9 software coupled with an
Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA,
USA). The analog signal was filtered at either 2 or 5 kHz and
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visualized at 106and 406using an Axioskop 2FS Plus microscope
(Carl Zeiss, Thornwood, NY, USA) equipped with infrared,
differential interference contrast detection capabilities (Dage MT1,
CCD100). The patch pipettes were fabricated from borosilicate
glass (Hilgenberg #1405002, Malsfeld, Germany) to yield pipette
resistance ranges from 5–8 MV. The OB pipette solution
contained (in mM): 135 potassium gluconate, 10 KCl, 10 HEPES,
10 EGTA, 1 MgCl2, 0.3 Tris GTP, and 4 MgATP; 285–295
mOsm, pH 7.3. Mitral cell bodies were confirmed by soma size
(15–30 mm) in the mitral cell layer [34,45] and as previously
optimized using Thy1-gfp transgenic mice [33]. Cells that failed to
have a resting membrane potential of at least 250 mV, a stable
input resistance of at least 150 MV, and repetitive spiking in
response to current injection were discarded from analysis due to
biophysical indicators of poor health. Resting membrane potential
was recorded, and adjusted to 265 mV for consistency between
cells [34,45]. The presented values were not adjusted for the
214 mV calculated junction potential. Cells were continuously
perfused with standard ACSF plus synaptic blockers (5 mM
NBQX and 25 mM APV; Ascent Scientific, Princeton, NJ)
(Ismatec; 2 ml/min). Cells were injected with a series of 10
current steps ranging from 250 to +175 pA for 1000 ms. After
establishing baseline evoked responses, the bath solution was
changed to one containing: cleavage resistant BDNF (10 ng/ml),
proBDNF (10 ng/ml), or margatoxin (MgTX) (1 nM; EMD
Chemicals, San Diego, CA, USA). After approximately ten
minutes of neurotrophin or toxin bath application, the cells were
again injected with the series of current steps. The evoked action
potential firing frequency (Hz) and interspike interval (ISI) analyses
were computed using Clampfit 9 software (Molecular Devices).
Each parameter was calculated for the duration of the one second
current step. Analyses were performed prior and subsequent to
bath application of neurotrophin or toxin so that a blocked design
statistical metric could be applied. Prizm software (version 4,
GraphPad, San Diego, CA, USA) was used to determine statistical
significance at the 95% confidence level with a factorial (or block
designed) two-way analysis of variance (ANOVA) for neurotrophin
or toxin treatment effect followed by Bonferroni post tests to
separately compare the effect at each current step.
Intranasal delivery
Neurotrophin intranasal delivery (IND) was performed as
described previously [75]. Briefly, P 30–35 mice were hand-
restrained, placed in a supine position, and given three, ten
microliter drops of10 ng/ml BDNF or proBDNF into both nares
simultaneously. A 0.01% BSA/PBS neurotrophin diluent was used
as a vehicle control (PBS). Mice were held supine for 5–10 sec after
delivery to ensure all fluid was inhaled. A total of ninety microliters,
or three sequential deliveries, were administered to each mouse per
day for 5 days. The IND protocol was conducted at 2 pm (circadian
time). Intranasally delivered insulin-like growth factor reaches the
OB with an efficiency of 0.11% [76]. Based on this efficiency, the
molecular weight of BDNF, and the mass of the mouse brain [77],
the effective dose reaching the OB was calculated to be between 0.2
to 4 nM BDNF, which is close to the reported concentration of
BDNF inthe OB[40,41].Onday6ofthe experiment,animalswere
perfused using paraformaldehyde dissolved in phosphate-buffered
saline(4%PFA/PBS).The OBswere dissectedand post-fixed in4%
PFA/PBS for 4 hours. OBs were cryoprotected by incubation in
30% sucrose/PBS overnight at 4uC and then stored in optimal
cutting temperature medium (Sakura, Torrance, CA, USA) at
280uC until further use. Sixteen micrometer coronal sections were
cut on a crytostat (Leica CM1850, Wetzlar, Germany), placed onto
pre-treated slides (Superfrost Plus, Fisher), and stored at 220uC
until use for immunofluorescence microscopy.
Unilateral-naris occlusion procedures
Postnatal day (P) 30–35 mice were anesthetized with isoflurane
and the left nariswas cauterizedusing a heatedmetal probeinserted
1–2 mm into the nostril as described previously [11,13,30]. Scar
formation resulted in permanent unilateral naris-closure. Complete
closure of the cauterized nostril was confirmed by visual
examination under a dissecting microscope at five days following
the procedure. Sham animals were anesthetized and then the
heated metal probe was placed on the tip of the snout. Naris or
sham occlusions were performed at 2 pm (circadian time), a time at
which the mice in our colony briefly awaken for a meal.
Immunofluorescence Microscopy
Frozen sections were air-dried on the bench for 60 minutes, re-
hydrated with PBS, and then incubated for 60 minutes in blocking
solution (5% normal goat serum/2.5% BSA/0.3% Triton in PBS).
After the blocking step, sections were rinsed with 0.3% Triton/PBS
and incubated with antiserum diluted in blocking solution at 4uCi n
a darkened, humidified chamber. The incubation was performed
overnight. The immunofluorescence signal was detected with either
goat anti-rabbit Cy3 or goat anti-mouse Cy3 secondary antisera
diluted in PBS (1:400; Jackson Immunoresearch, PA, USA).
Following three washes in PBS, cells were counter-stained with a
nuclear stain by incubating slides for five-minutes in diamidino-
phenyindole (DAPI, Fisher) in PBS (1:20,000), washed again in
PBS and coverslipped with Fluoromount G (SouthernBiotech,
Birmingham, AL, USA) to prevent photobleaching. The following
controls were conducted to ensure the technical and biological
relevance of the immunofluorescent images: omission of primary
antisera, an IND of vehicle group, a sham naris-occlusion group,
and the within animal control comparing the olfactory bulbs from
the open and occluded nares from the naris-occluded animals.
Omission of the primary antisera abolished immunofluorescence
and representative biological controls are shown. Image brightness
and contrast were adjusted with Adobe Photoshop CS (Adobe
Systems Inc., San Jose, CA) for maximal clarity.
Anatomical analysis
Three animals of each treatment condition (sham and naris
occluded; intranasal delivery of PBS, proBDNF or matureBDNF)
were sampled. Immunoreactive glomerular cells (including both
peri- and juxtaglomerular cells) within 12 fields of view (each
93,500 mm
2) per animal were counted using Neurolucida (Micro-
BrightField, Colchester, VT, USA). These 12 fields of view were
from representative sections evenly distributed and separated by
approximately 460 mm from the rostral to caudal aspects of the
OB (3 sections total). On each section, a field of view was taken
from the dorsal, ventral, medial, and lateral glomerular layers of
the OB and the depth of focus adjusted once for each field of view
to obtain the largest and most clear nuclei as seen with DAPI
labeling. Immunoreactive-TH cells had clearly defined soma and
perinuclear labeling. Activated-caspase 3 immunoreactive cells
had punctate labeling near the nucleus as defined by DAPI
staining. The counts from these 12 fields of view were then
averaged for the analysis. Neurolucida was used to trace entire OB
sections that contained the quantified fields of view. The total area
of these sections was calculated by summing the area from each of
three sections per animal and per treatment as measured by
Neurolucida. Using Prizm software (version 4, GraphPad, San
Diego, CA, USA), statistical significance was calculated and
determined at the 95% confidence level via a one-way analysis of
Olfactory Bulb Precursor Neurotrophin Function
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test to separately compare the cell counts across treatment groups.
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